NuDiscovery
Multi-Modal Disease understanding. Our Agentic system works as the guide to tap into the unknown

Modalities
Programs
Scientists
Year Founded
Premise
At Micro CRISPR, we believe the convergence of Advanced Biology and Artificial Intelligence has brought medicine to a defining inflection point; one that is poised to shape a new era in healthcare.
By building an integrated technology platform that can convert biological insight into transformative clinical outcomes; We exists to enable this change.
We envision a future in which medicines are increasingly programmable rather than discovered by chance, scalable rather than constrained by complexity, and accessible to all.
The architecture
This is the whole company in one diagram. On top sit six biology platforms the physical means by which a medicine actually gets made. Underneath sits NUVO Labs, the AI engine that chooses the targets, designs the candidates, predicts what will fail and plans how to build the rest. Not six teams with six tool sets. Six platforms drawing on one intelligence, and feeding it back.
Next-generation cell therapy built on our proprietary engineering platform with plug-and-play synthetic modules for safety, potency and persistence, plus allogeneic-ready and in-vivo CAR programs.
The engine designs the construct and payload architecture, recommends which genes to modify for enhance persistence and exhaustion behavior, cleaner safety profile, etc
Nuvo Labs
Where AI meets Biology.
We combine AI, physics, chemistry, and biological intelligence to move from disease insight to novel molecules to real world validation.
Multi-Modal Disease understanding. Our Agentic system works as the guide to tap into the unknown

Physics Grounded AI explorative method of unlocking unknown chemical spaces

State of Art synthesis and BioLab facilities, Designed for AI native biology and effective feedback loops

Careers
Biologists, chemists and ML engineers on the same programs building what the biology needs.
Partnership
Partner across discovery, development, manufacturing and commercialisation fast to first data.